Lido Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,710
| Closed | -$16.5K | – | 1441 |
|
|
2024
Q4 | $16.5K | Hold |
1,710
| – | – | ﹤0.01% | 1314 |
|
|
2024
Q3 | $31.8K | Sell |
1,710
-1,743
| -50% | -$32.4K | ﹤0.01% | 1246 |
|
|
2024
Q2 | $57.4K | Hold |
3,453
| – | – | ﹤0.01% | 1196 |
|
|
2024
Q1 | $60K | Hold |
3,453
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q4 | $54K | Hold |
3,453
| – | – | ﹤0.01% | 1147 |
|
|
2023
Q3 | $171K | Hold |
3,453
| – | – | ﹤0.01% | 975 |
|
|
2023
Q2 | $270K | Hold |
3,453
| – | – | ﹤0.01% | 878 |
|
|
2023
Q1 | $313K | Hold |
3,453
| – | – | ﹤0.01% | 781 |
|
|
2022
Q4 | $407K | Hold |
3,453
| – | – | 0.01% | 605 |
|
|
2022
Q3 | $626K | Hold |
3,453
| – | – | 0.01% | 438 |
|
|
2022
Q2 | $309K | Hold |
3,453
| – | – | ﹤0.01% | 643 |
|
|
2022
Q1 | $536K | Hold |
3,453
| – | – | 0.01% | 519 |
|
|
2021
Q4 | $1.03M | Hold |
3,453
| – | – | 0.01% | 375 |
|
|
2021
Q3 | $1.99M | Sell |
3,453
-14,792
| -81% | -$8.52M | 0.03% | 239 |
|
|
2021
Q2 | $8.28M | Buy |
+18,245
| New | +$8.28M | 0.12% | 93 |
|